Overview

Corporate ProfileNantHealth is a next-generation, evidence-based, personalized healthcare company enabling improved patient outcomes and more effective treatment decisions for critical illnesses. NantHealth‘s unique systems-based approach to personalized healthcare integrates novel diagnostics with large-scale, biometric and phenotypic data to track patient outcomes and deliver precision medicine. In addition, NantHealth’s adaptive learning system, CLINICS, continuously improves decision-making and further optimizes our clinical pathways and decision algorithms over time.
Stock Quote NH (Common Stock) $1.39 - 0.04 (2.80%)
ExchangeNASDAQ GS
Volume40,645
Today's Open$1.43
Previous Close$1.43
Data as of 11/14/18 4:00 p.m. ET
Refresh quote

Data provided by Nasdaq. Minimum 15 minutes delayed.

Stock Chart
Stock chart for: NH.O.  Currently trading at $1.39 with a 52 week high of $4.05 and a 52 week low of $1.24.
Recent News

November 07, 2018

NantHealth to Report 2018 Third-Quarter Financial Results and Host Conference Call on Thursday, November 15

--Slight Delay in Reporting Financial Results, Due to Effects of Hurricane Michael-- CULVER CITY, Calif.--(BUSINESS WIRE)--Nov. 7, 2018-- NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced that it will report financial results for its 2018 third quarter on Thursday, November 15, 2018, after market close. NantHealth management will host a conference call that same day at 1:30 p....

Read More >

November 07, 2018

NantHealth®, B. Braun Australia, GE Healthcare and iProcedures Join Forces to Bridge Connectivity Gap Between Patient Devices, Data and Medical Records at the Healthcare Information and Management Systems Society (HIMSS) Asia Pacific Conference

NantHealth demonstrates new DeviceConX™ features including enterprise support for larger health systems and high fidelity waveform capture BRISBANE, Australia & CULVER CITY, Calif.--(BUSINESS WIRE)--Nov. 7, 2018-- NantHealth (NASDAQ: NH), a leader in breakthrough cancer research and solutions to improve patient care and lower healthcare costs, today announced a collaboration with B. Braun Australia, GE Healthcare and iProcedures to demonst...

Read More >

November 07, 2018

NantHealth® Advances Clinician Productivity and Critical Patient Information Access with Enhancements to DeviceConX™

New DeviceConX Enhancements Showcased at the Healthcare Information and Management Systems Society (HIMSS) Interoperability Showcase™ Asia Pacific Conference and Exhibition Featuring NantHealth, B. Braun Australia, GE Healthcare, and iProcedures BRISBANE, Australia & CULVER CITY, Calif.--(BUSINESS WIRE)--Nov. 7, 2018-- NantHealth (NASDAQ: NH), a leader in breakthrough cancer research and data solutions that improve patient care and...

Read More >

Upcoming Events
DateTitle
11/15/18 4:30 p.m. ET
Q3 2018 NantHealth Earnings Conference Call